Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD

S. Haeussermann, D. Acerbi, P. Brand, G. Poli, T. Meyer (Gauting, Germany; Parma, Italy)

Source: Annual Congress 2006 - Evaluation of drugs for lung disease
Session: Evaluation of drugs for lung disease
Session type: Thematic Poster Session
Number: 1256
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Haeussermann, D. Acerbi, P. Brand, G. Poli, T. Meyer (Gauting, Germany; Parma, Italy). Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 1256

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung deposition of formoterol HFA in healthy volunteers, asthmatic and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 314s
Year: 2005

The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease
Source: Eur Respir J 2003; 22: Suppl. 45, 51s
Year: 2003

Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012


COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021


Systemic and airways inflammation in healthy subjects and COPD patients of different ages
Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Year: 2007


Influence of smoking on airway and systemic inflammation in healthy subjects and COPD patients
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010

Lung function in the patients with COPD and with the combination COPD and grownup's diabetes
Source: Eur Respir J 2003; 22: Suppl. 45, 538s
Year: 2003

Lung deposition of BDP/formoterol HFA pMDI in healthy subjects, asthmatic and COPD patients
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008


Hospitalisations in subjects with and without COPD
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Mucocilary clearance of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Neutrophils and spirometry changes in COPD patients treated with roflumilast
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004

Patients at risk for COPD compared to patients diagnosed with COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009


SPECT measurement of perfused lung volume in patients with COPD, patients with restrictive lung disease and healthy volunteers
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010


Assessment of nicotine dependence in healthy people and patients with chronic pulmonary obstructive disease or bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 134s
Year: 2002

Sexuality in patients with asthma and/or COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003

Sexuality in patients with asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 273s
Year: 2005

Longitudinal study of lung function in exacerbations of COPD patients during 10 years
Source: Eur Respir J 2003; 22: Suppl. 45, 276s
Year: 2003

Effects of lisinipril on hypertensive COPD and asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 718s
Year: 2005

A study of the airway mycobiome in COPD patients and controls
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019